L

Lord Tarassenko (CB)

Speaking in the House of Lords on 13 October 2026

Debate

Health Bill

Contribution

My Lords, I also congratulate my noble friend Lord Wormald on his excellent and engaging speech informed by his eight and a half years as Permanent Secretary of the Department of Health and Social Care, working with, I believe, seven Secretaries of State during that time. I declare an interest as I have held an honorary contract with the Oxford University Hospitals NHS Foundation Trust for the past decade enabling me to be an investigator on research projects involving patient data. I welcome this Bill, especially the legal framework for sharing information through a single patient record. This represents a wonderful opportunity to improve patient care through the linking of multiple sources of health data, but delivering on this objective is fraught with technical difficulties and not just reading PDF files. Interoperability is an issue which continues to plague the NHS, and it is not clear yet how the single patient record data standards will be set, maintained and made binding on suppliers. There is also an opportunity to expand the legal framework underpinning the single patient record by giving our NHS data the status it deserves, making it a sovereign data asset at the core of an NHS digital sovereignty strategy. The first consequence of this would be a binding requirement for the single patient record data to be stored in servers located on British soil. Secondly, we have been told by DHSC that there will be multiple contracts awarded for the development of the single patient record. An NHS digital sovereignty strategy would prioritise those technologies whose data, control and support remain within UK jurisdiction to reduce our reliance on foreign technologies within the NHS. The selection of Kainos Software Limited, a subsidiary of a FTSE 250 company, as the development partner for UK Biobank’s output checking system after a public procurement process shows that there are UK-owned companies capable of delivering state-of-the-art software solutions for the NHS. We have been told that the use of data for research is not within the scope of the Bill, but the SPR systems, datasets and governance arrangements will also shape how health data is accessed and used for research. It would be a mistake, as the Health Data Research Service develops, not to address the barriers affecting this access. For example, the control of patient information—COPI—regulatory framework was first introduced as a temporary measure in 2002, more than 20 years ago, and we cannot wait for its reform to happen at some indeterminate time in the future. The Bill needs to set out a timetable for the Secretary of State to complete the process of reforming the COPI regime, following public consultation, within a fixed period of Royal Assent. Recent polling has put the percentage of those willing to share their de-identified health records for research at between 75% and 80%, but such a high percentage depends on the public maintaining a high level of trust. Again, this will be easier if the single patient record is given the status of sovereign data asset that we all own within an NHS digital sovereignty strategy. A further implication of this status would be to set up a hierarchy of access to de-identified patient data from the single patient record for research, similar to that operated by MHRA for the primary care CPRD datasets, but expanded. That should soon be followed by the development of our own sovereign AI model capability for the NHS, using longitudinal datasets from the single patient record, linking primary care and secondary care data with outcome data. These models would enable the early detection of diseases such as cancer and cardiovascular disease, and would contribute to the prevention agenda. The use of the single patient record has the potential to improve direct patient care, but it is also an opportunity, through health data research, to make the UK a healthier nation at the end of the current 10-year plan for the NHS. We must not miss either opportunity.

More from Lord Tarassenko (CB)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.